177 related articles for article (PubMed ID: 11046139)
41. CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells.
Lee AW; Nambirajan S; Moffat JG
Oncogene; 1999 Dec; 18(52):7477-94. PubMed ID: 10602507
[TBL] [Abstract][Full Text] [Related]
42. Bypass of telomere-dependent replicative senescence (M1) upon overexpression of Cdk4 in normal human epithelial cells.
Ramirez RD; Herbert BS; Vaughan MB; Zou Y; Gandia K; Morales CP; Wright WE; Shay JW
Oncogene; 2003 Jan; 22(3):433-44. PubMed ID: 12545164
[TBL] [Abstract][Full Text] [Related]
43. Cyclin-dependent kinases regulate the antiproliferative function of Smads.
Matsuura I; Denissova NG; Wang G; He D; Long J; Liu F
Nature; 2004 Jul; 430(6996):226-31. PubMed ID: 15241418
[TBL] [Abstract][Full Text] [Related]
44. Deregulation of Internal Ribosome Entry Site-Mediated p53 Translation in Cancer Cells with Defective p53 Response to DNA Damage.
Halaby MJ; Harris BR; Miskimins WK; Cleary MP; Yang DQ
Mol Cell Biol; 2015 Dec; 35(23):4006-17. PubMed ID: 26391949
[TBL] [Abstract][Full Text] [Related]
45. Analysis of central regulatory pathways in p53-deficient primary cultures of malignant fibrous histiocytoma exposed to ifosfamide.
Schlott T; Taubert H; Fayyazi A; Schweyer S; Bartel F; Korabiowska M; Brinck U
Anticancer Res; 2004; 24(6):3819-29. PubMed ID: 15736417
[TBL] [Abstract][Full Text] [Related]
46. Restoration of transforming growth factor-beta signaling enhances radiosensitivity by altering the Bcl-2/Bax ratio in the p53 mutant pancreatic cancer cell line MIA PaCa-2.
Ahmed MM; Alcock RA; Chendil D; Dey S; Das A; Venkatasubbarao K; Mohiuddin M; Sun L; Strodel WE; Freeman JW
J Biol Chem; 2002 Jan; 277(3):2234-46. PubMed ID: 11694525
[TBL] [Abstract][Full Text] [Related]
47. Enforced CDK4 expression in a hematopoietic cell line confers resistance to the G1 arrest induced by ionizing radiation.
Reed MF; Liu VF; Ladha MH; Ando K; Griffin JD; Weaver DT; Ewen ME
Oncogene; 1998 Dec; 17(23):2961-71. PubMed ID: 9881698
[TBL] [Abstract][Full Text] [Related]
48. Transforming growth factor-beta 1 stimulates or inhibits cell growth via down- or up-regulation of p21/Waf1.
Miyazaki M; Ohashi R; Tsuji T; Mihara K; Gohda E; Namba M
Biochem Biophys Res Commun; 1998 May; 246(3):873-80. PubMed ID: 9618305
[TBL] [Abstract][Full Text] [Related]
49. Transforming growth factor beta-induced activation of cyclin E-cdk2 kinase and down-regulation of p27Kip1 in C3H 10T1/2 mouse fibroblasts.
Ravitz MJ; Yan S; Herr KD; Wenner CE
Cancer Res; 1995 Apr; 55(7):1413-6. PubMed ID: 7882344
[TBL] [Abstract][Full Text] [Related]
50. PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway.
Tan M; Wang Y; Guan K; Sun Y
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):109-14. PubMed ID: 10618379
[TBL] [Abstract][Full Text] [Related]
51. Ectopic expression of Cdk6 circumvents transforming growth factor-beta mediated growth inhibition.
Zhang F; Taipale M; Heiskanen A; Laiho M
Oncogene; 2001 Sep; 20(41):5888-96. PubMed ID: 11593394
[TBL] [Abstract][Full Text] [Related]
52. Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas.
Cheng Y; Pang JC; Ng HK; Ding M; Zhang SF; Zheng J; Liu DG; Poon WS
Histopathology; 2000 Nov; 37(5):437-44. PubMed ID: 11119125
[TBL] [Abstract][Full Text] [Related]
53. Mutant p53 promotes tumor cell malignancy by both positive and negative regulation of the transforming growth factor β (TGF-β) pathway.
Ji L; Xu J; Liu J; Amjad A; Zhang K; Liu Q; Zhou L; Xiao J; Li X
J Biol Chem; 2015 May; 290(18):11729-40. PubMed ID: 25767119
[TBL] [Abstract][Full Text] [Related]
54. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.
Fuxe J; Akusjärvi G; Goike HM; Roos G; Collins VP; Pettersson RF
Cell Growth Differ; 2000 Jul; 11(7):373-84. PubMed ID: 10939591
[TBL] [Abstract][Full Text] [Related]
55. p53, p16 and cyclin D1: molecular determinants of radiotherapy treatment response in oral carcinoma.
Jayasurya R; Francis G; Kannan S; Lekshminarayanan K; Nalinakumari KR; Abraham T; Abraham EK; Nair MK
Int J Cancer; 2004 May; 109(5):710-6. PubMed ID: 14999779
[TBL] [Abstract][Full Text] [Related]
56. Adenovirus E1A antagonizes both negative and positive growth signals elicited by transforming growth factor beta 1.
de Groot RP; Kranenburg O; de Wit L; van den Eijnden-van Raaij J; Mummery C; van der Eb AJ; Zantema A
Cell Growth Differ; 1995 May; 6(5):531-40. PubMed ID: 7647036
[TBL] [Abstract][Full Text] [Related]
57. Translational Control in
Swiatkowska A; Dutkiewicz M; Zydowicz-Machtel P; Szpotkowska J; Janecki DM; Ciesiołka J
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671760
[TBL] [Abstract][Full Text] [Related]
58. Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S-specific cyclin-dependent kinases and by inducing p53 and p21Cip1.
Meng LH; Zhang H; Hayward L; Takemura H; Shao RG; Pommier Y
Cancer Res; 2004 Dec; 64(24):9086-92. PubMed ID: 15604277
[TBL] [Abstract][Full Text] [Related]
59. Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein.
Landers JE; Cassel SL; George DL
Cancer Res; 1997 Aug; 57(16):3562-8. PubMed ID: 9270029
[TBL] [Abstract][Full Text] [Related]
60. Reduction in cyclin D1/Cdk4/retinoblastoma protein signaling by CRE-decoy oligonucleotide.
Park YG; Park S; Lim SO; Lee MS; Ryu CK; Kim I; Cho-Chung YS
Biochem Biophys Res Commun; 2001 Mar; 281(5):1213-9. PubMed ID: 11243864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
